MARATTO

article · Współczesna Onkologia

The antitumour efficacyof hesperidin vs. cisplatin againstnon‑small lung cancer cellsA549 and H460 via targetingthe miR‑34a/PD-L1/NF-κB signallingpathway

2024Open accessSuez Canal University

Abstract

Our study demonstrated that hesperidin extract could significantly inhibit non-small lung cancer cell growth by induction of the apoptosis signalling pathway. Therefore, hesperidin might open novel strategies for effective and safe cancer treatment and reduce the adverse side effects of several chemotherapeutic treatments such as cisplatin.

Research topics

  • Genomics, phytochemicals, and oxidative stress
  • Bioactive Compounds and Antitumor Agents
  • Chemotherapy-induced organ toxicity mitigation

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5114/wo.2024.141648

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.